Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.240
+0.040 (3.33%)
Jul 10, 2026, 10:34 AM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.52 billion as of July 9, 2026. Its market cap has decreased by -33.33% in one year.
Market Cap
2.52B
Enterprise Value
2.80B
Revenue
1.92B
Ranking
n/a
PE Ratio
11.98
Stock Price
1.24
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.52B, a decrease of -62.04%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 2.56B | -32.64% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 3.18B |
| Laekna | 3.03B |
| BioDlink International Company | 2.77B |
| Antengene Corporation | 2.72B |
| Beijing Luzhu Biotechnology | 2.53B |
| HJ Science | 2.50B |
| TYK Medicines | 2.46B |
| PegBio | 2.22B |